BioSpace News Archive

CryoLife, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced the appointment of Anthony “Tony” Semedo to its Board of Directors effective October 1, 2021.

Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that Dane C. Andreeff, President and Chief Executive Officer, will present at the Benzinga Healthcare Small Cap Conference.

Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company developing transformative therapies for metabolic diseases associated with chronic glucose imbalance, today presented results from a natural history study designed to quantify the extent of hypoglycemia in congenital hyperinsulinism (HI) patients on standard of care therapies.

SeaSpine Holdings Corporation today announced the Company will present at the Cantor Virtual Global Healthcare Conference on Monday, September 27, 2021, beginning at 8:00 am ET.

Arcturus Therapeutics Holdings Inc. today announced that Arcturus’ President & CEO, Joseph Payne, met with the President of Vietnam, Nguyen Xuan Phuc, and the CEO of the Vingroup, Nguyen Viet Quang, in New York City to discuss the ongoing collaboration recently announced between Arcturus and Vingroup related to the manufacturing supply of COVID-19 vaccines

Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics, today announced that Purnanand Sarma, Ph.D., Immunome’s President and CEO, will present at the Cantor Global Healthcare Conference.

Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company using its innovative TransCon™ technologies to potentially create new treatments to make a meaningful difference in patients’ lives, today announced 58-week BMD data from central lab reading in the PaTH Forward Trial, a global phase 2 trial of its investigational product candidate TransCon PTH in adult subjects with hypoparathyroidism (HP).

Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Cantor Virtual Global Healthcare Conference on Wednesday, Sept. 29, 2021 at 8:40 a.m. ET

Vaxart, Inc. (NASDAQ: VXRT), today announced that one of the company’s senior scientists, Susan Johnson PhD, will present at both ID Week 2021 and the 15 th Vaccine Congress.

ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced the appointment of Helen M. Thackray, MD, FAAP to its Board of Directors.